diadenosine 5',5''''-p1,p6-hexaphosphate has been researched along with pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid in 2 studies
Studies (diadenosine 5',5''''-p1,p6-hexaphosphate) | Trials (diadenosine 5',5''''-p1,p6-hexaphosphate) | Recent Studies (post-2010) (diadenosine 5',5''''-p1,p6-hexaphosphate) | Studies (pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid) | Trials (pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid) | Recent Studies (post-2010) (pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid) |
---|---|---|---|---|---|
52 | 0 | 5 | 598 | 0 | 83 |
Protein | Taxonomy | diadenosine 5',5''''-p1,p6-hexaphosphate (IC50) | pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid (IC50) |
---|---|---|---|
P2X purinoceptor 1 | Rattus norvegicus (Norway rat) | 0.5495 | |
P2X purinoceptor 2 | Rattus norvegicus (Norway rat) | 1.6 | |
P2X purinoceptor 3 | Rattus norvegicus (Norway rat) | 0.24 | |
P2X purinoceptor 1 | Mus musculus (house mouse) | 0.099 | |
P2X purinoceptor 4 | Rattus norvegicus (Norway rat) | 2.6 | |
P2X purinoceptor 6 | Rattus norvegicus (Norway rat) | 2 | |
P2X purinoceptor 3 | Homo sapiens (human) | 0.24 | |
P2X purinoceptor 5 | Homo sapiens (human) | 8.45 | |
P2X purinoceptor 4 | Homo sapiens (human) | 6.1 | |
P2X purinoceptor 7 | Homo sapiens (human) | 1.18 | |
P2X purinoceptor 2 | Homo sapiens (human) | 2.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cinkilic, O; Jankowski, J; Schlüter, H; Tepel, M; van der Giet, M; Zidek, W | 1 |
O'Kane, EM; Stone, TW | 1 |
2 other study(ies) available for diadenosine 5',5''''-p1,p6-hexaphosphate and pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid
Article | Year |
---|---|
Evidence for two different P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney.
Topics: Adenosine Triphosphate; Animals; Dinucleoside Phosphates; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Male; Perfusion; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred WKY; Receptors, Purinergic P2; Renal Artery; Renal Circulation; Suramin; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Characterisation of ATP-induced facilitation of transmission in rat hippocampus.
Topics: Adenosine Deaminase; Adenosine Triphosphate; Animals; Caffeine; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Electric Stimulation; Evoked Potentials; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Purinergic P1 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Wistar; Suramin; Synaptic Transmission; Theophylline | 2000 |